Clinical trial Recruiting at 1 site Interventional Ages 75 and up

Do high blood levels of psychoactive drugs make falls worse in people 75 and older?

Official title: Consequence of Plasma Concentrations of Psychoactive Drugs Located Beyond Therapeutic Ranges on Severity of Falls in Patients Over 75 Years Old

Run by University Hospital, Caen · NCT05991037 · Data updated 2026-11-12

See if people 75 and older who have higher-than-usual blood levels of psychoactive drugs have more serious injuries after a fall.

More Fall trials

Quick facts

Study typeInterventional
Ages75 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversity Hospital, Caen
Academic / other
Locations1 site (Caen)
StatusRecruiting
StartedMay 22, 2024
Main results expectedMay 30, 2027
Study endsMay 30, 2028
Registry record updatedJuly 25, 2025
Trial IDNCT05991037 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 75 or older who were hospitalized after a fall, are taking at least one listed psychoactive drug, can give consent, and were mobile before admission.

Probably not a fit

People under 75, those not taking psychoactive drugs, patients who fell due to seizures or Parkinsonian causes, those not hospitalized, or those in imminent end-of-life care are unlikely to benefit from this study's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study will enroll 400 patients aged 75 and over who are hospitalized after a fall and who take at least one psychoactive medication. Blood samples taken in the emergency room will be analyzed by liquid chromatography–tandem mass spectrometry to measure plasma concentrations of psychoactive drugs. Clinical and injury-severity data will be collected during the hospital stay by a geriatrician and used to compare the proportion of serious traumatic consequences between patients with plasma overdoses and those with concentrations in the usual therapeutic range. The study is expected to run for about three years at Caen University Hospital.

Why it matters

Potential benefit: If successful, the results could help doctors identify older patients at higher risk of severe fall injuries and guide safer prescribing or monitoring of psychoactive medications.

How similar studies have gone: Epidemiological studies have linked the use and number of psychoactive drugs to fall risk, but few prior studies have examined blood drug concentrations and fall severity, so this approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient (male, female) aged 75 and over admitted to the emergency room for a fall and for whom hospitalization (in geriatrics or not) after going to the emergency room is planned
* Patient consuming at least one psychoactive drug from the list provided in the protocol
* Patient able to move before hospitalization with or without technical assistance
* Patient who signed the consent
* Patient subject to the social security system

Exclusion Criteria:

* Patient not requiring hospitalization after going to the emergency room
* Patient having fallen for more than 12 hours before inclusion in the study (time of sampling) \[risk of excessive elimination of certain drugs with short half-lives\]
* Parkinsonian patient or patient who has fallen following a convulsive attack
* Patient with a life-threatening prognosis in the very short term (state of shock, palliative care planned from the emergency room)
* Patient in wheelchair or bedridden
* Adult under legal protection, guardianship, curators
* Patient not understanding the French language

Where it's running

  • Caen University Hospital
    Caen, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.